H7N3 avian influenza virus live attenuated vaccine (PATH/Microgen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameH7N3 avian influenza virus live attenuated vaccine (PATH/Microgen)
Drug Alias Namelive attenuated monovalent vaccine (PATH/Microgen)
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRussian Federation
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPath
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMicrogen State Scientific IndustrialPath
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A